Tag: Novo Nordisk obesity treatment trial results
Novo Nordisk’s Next-Generation Obesity Treatment Falls Short in Key Trial
Novo Nordisk, a prominent player in the pharmaceutical industry, recently faced a setback with its next-generation obesity treatment, CagriSema. The highly anticipated treatment showed...